Patient education, evidence-based treatment and biomarkers in HFrEF

touchPANEL DISCUSSION for touchCARDIO Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement evidence-based therapies into practice including the potential impact of emerging therapies on treatment selection, and the role of biomarkers in diagnosing, monitoring and determining treatment course for individuals with HFrEF. The experts Prof. Piotr Ponikowski, Wrocław Medical University, Wrocław, Poland Prof. Adriaan A Voors, University Medical Centre Groningen, Groningen, The Netherlands Dr Stephen Greene, Duke University, Durham, NC, USA This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent educational grant from Bayer, Merck & Co and AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchcardioime.org/aiming-for-improved-outcomes-in-hfref